Evidence map›Paper›PMID 41639532›Full record

ArticleMedical & biological engineering & computing2026

An explainable ensemble for diabetic retinopathy grading with a novel confidence quality factor and configurable heatmaps.

Javier Civit-Masot, Francisco Luna-Perejon, Luis Muñoz-Saavedra, José María Rodríguez Corral, Manuel Domínguez-Morales, Anton Civit

Abstract read
In one paragraph

Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Javier Civit-Masot *Robotics and Computer Technology Lab, ETSII, Universidad de Sevilla, Reina Mercedes s/n, Seville, 41018, Spain. mjavier@us.es.ORCID http://orcid.org/0000-0003-3306-3537
Francisco Luna-Perejon *Robotics and Computer Technology Lab, ETSII, Universidad de Sevilla, Reina Mercedes s/n, Seville, 41018, Spain.
Luis Muñoz-Saavedra *Robotics and Computer Technology Lab, ETSII, Universidad de Sevilla, Reina Mercedes s/n, Seville, 41018, Spain.
José María Rodríguez Corral *Applied Robotics Research Group, School of Engineering, Universidad de Cádiz, Avda. Universidad de Cádiz, 10, Puerto Real, Cádiz, 11519, Spain.
Manuel Domínguez-Morales *Robotics and Computer Technology Lab, ETSII, Universidad de Sevilla, Reina Mercedes s/n, Seville, 41018, Spain.
Anton Civit *Robotics and Computer Technology Lab, ETSII, Universidad de Sevilla, Reina Mercedes s/n, Seville, 41018, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While current artificial intelligence (AI) tools aid in detecting diabetic retinopathy (DR), they face significant challenges that limit their clinical utility. Most are restricted to binary (referable vs. non-referable) screening and operate as “black boxes,” lacking the detailed, transparent explanations required for diagnostic confidence. This study addresses these gaps by introducing a novel, explainable ensemble-based approach for detailed DR grading. Our system utilizes a parallel ensemble of two efficient deep learning networks, EfficientNetV2 and ConvNeXt, to perform a full five-class international clinical diabetic retinopathy (ICDR) classification. The proposed model achieves state-of-the-art performance, with 96.7% accuracy and an Area Under the Curve (AUC) over 96% for all classes on a public dataset. More importantly, it provides a comprehensive diagnostic report designed to enhance clinical trust and utility. This report features multiple, configurable superimposed heatmaps, two probability-ordered diagnostic suggestions, and a novel quality factor that estimates the confidence of the prediction. By offering richer, more transparent, and interactive explanations, our system moves beyond simple screening to function as a valuable diagnostic assistance tool for ophthalmologists and other healthcare professionals.

Indexed as

Diabetic RetinopathyArea Under CurveArtificial IntelligenceDeep LearningEnsemble LearningHumansClinical decision supportDeep learningDiabetic retinopathyExplainable AI (xAI)Explainable ensembleICDRMedical imaging

Identifiers

PMID41639532
PMCPMC13121246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.